(IN BRIEF) Sanofi has simplified its contractual arrangements with AstraZeneca and Sobi for the development and commercialization of Beyfortus (nirsevimab) in the United States. Under the new arrangements, Sanofi will have full commercial control of nirsevimab in the U.S. Sanofi … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech
Tagged AstraZeneca, Beyfortus, commercialization, contractual agreements, nirsevimab, partnership, Sanofi, Sobi, USA
(PRESS RELEASE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, the world’s leading testing, inspection and certification company, has announced the company won five awards at the 2022 CRO Leadership Awards underlining its industry-leading work. The categories the company won award in … Read the full press release
Posted in Awards, Business, Industrial, Management, News, Science, Switzerland, Technology
Tagged analytical testing, Antwerp University Hospital, Awards, Clinical Pharmacology Unit, clinical research, commercialization, cro, CRO Leadership Awards, CRO Quality Benchmarking, CROs, Ed Miseta, Health Science, Industry Standard Research, Johan Pype, life sciences, Manufacturing, SGS, survey
(COMMUNIQUÉ DE PRESSE) GENEVA, 29-Apr-2022 — /EuropaWire/ — SGS, le leader mondial des tests, de l’inspection et de la certification, a annoncé que la société a remporté cinq prix aux CRO Leadership Awards 2022, soulignant son travail de pointe dans … Read the full press release
Posted in Awards, Business, Industrial, Management, News, Science, Switzerland
Tagged analytical testing, Antwerp University Hospital, Awards, Clinical Pharmacology Unit, clinical research, commercialization, cro, CRO Leadership Awards, CRO Quality Benchmarking, CROs, Ed Miseta, Health Science, Industry Standard Research, Johan Pype, life sciences, Manufacturing, SGS
Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple sclerosis (MS), making commercialization more efficient and eliminating future royalty payments Allows expansion of SAR442168 development program into other central … Read the full press release
Posted in Business, France, Healthcare, Investment, News, Pharma & Biotech
Tagged acquisition, allergic diseases, Arnaud Delepine, Ashleigh Koss, autoimmune diseases, biopharmaceutical, BofA Securities, Bruton tyrosine kinase, BTK inhibitor, BTK inhibitor ‘168, Centerview Partners LLC, Christopher Chai, commercialization, Cooley LLP, Eva Schaefer-Jansen, Evercore, Fara Berkowitz, Felix Lauscher, Gotshal & Manges LLP, John Reed M.D. Ph.D., Martin Babler, MS, multiple sclerosis, Nicolas Kressmann, pathophysiology, Paul Hudson, Paul Laland, Pharmaceutical, Principia, Principia Biopharma, PRN473 Topical, rilzabrutinib, Sanofi, SAR442168, Suzanne Greco, Weil, Yvonne Naughton
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
